Barium enema: does splitting the buscopan dose reduce patient discomfort, whilst maintaining image quality? - Trial ISRCTN32878249
Access comprehensive clinical trial information for ISRCTN32878249 through Pure Global AI's free database. This Not Applicable trial is sponsored by Department of Health and is currently status unknown. The study focuses on Procedure. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Department of Health
South Manchester University Hospitals NHS Trust (UK)
Timeline & Enrollment
Not Applicable
Sep 01, 2003
Jun 01, 2005
Summary
To investigate if splitting the 20 mg of Buscopan (hyoscine-butylbromide) into two doses of 10 mg each, with one dose being administered at the usual point in the examination, and the second dose being administered just before the final images are obtained, will decrease patient discomfort, with no loss of image quality.
ICD-10 Classifications
Data Source
ISRCTN Registry
ISRCTN32878249
Non-Device Trial